Benserazide Hcl (Benserazide Hcl)
Overview of Benserazide Hcl
Benserazide Hcl is used in pakinson's disease (mental disorder) with levodopa to reduce its side-effects by preventing peripheral breakdown of LEVODOPA, allowing reduced dosage and decreased side effects.
Indication of Benserazide Hcl
Benserazide Hcl is primarily indicated in conditions like Parkinsonism.
Contraindication of Benserazide Hcl
Benserazide (HCl) is contraindicated in conditions like Psychosis,Narrow-angle glaucoma.
Side Effects of Benserazide Hcl
The severe or irreversible adverse effects of Benserazide (HCl), which give rise to further complications include Postural hypotension, Psychiatric disturbances, Fluctuating disability, Dyskinesias.,Benserazide (HCl) produces potentially life-threatening effects which include Severe postural hypotension. which are responsible for the discontinuation of Benserazide (HCl) therapy.,The signs and symptoms that are produced after the acute overdosage of Benserazide (HCl) include Hypotension, Nausea, Vomiting, Cardiac arrhythmias, Chorea.,The symptomatic adverse reactions produced by Benserazide (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Elevated alkaline phosphatase, Elevated hepatic transaminases.
Precautions of Benserazide Hcl
Rapidly affects oxygenation and lung compliance and should be restricted to a highly supervised use in a clinical setting with immediate availability of clinicians experienced with intubation and ventilatory management of the premature infants. If transient episode of the bradycardia and decreased oxygen saturation occur, discontinue the dosing procedure and initiate measures to alleviate the condition, produces rapid improvements in lungs oxygenation and compliance that may require immediate reductions in ventilator settings and FiO2.